[1] |
Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan.
Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity, proliferation, and apoptosis of multiple myeloma cells
[J]. Journal of International Oncology, 2024, 51(3): 129-136.
|
[2] |
Gong Yan, Chen Honglei.
Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer
[J]. Journal of International Oncology, 2024, 51(3): 186-190.
|
[3] |
Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.
Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells
[J]. Journal of International Oncology, 2023, 50(9): 513-519.
|
[4] |
Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.
lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway
[J]. Journal of International Oncology, 2023, 50(4): 202-207.
|
[5] |
Chu Xuelei, Mao Yun, Xue Peng, Li Linlu, Chen Meichi, Yuan Chunsheng, Qin Xiaoyan, Zhu Shijie.
Effects of chemotherapy dose intensity on short-term efficacy in patients with advanced colon cancer: a study based on real-world data
[J]. Journal of International Oncology, 2022, 49(7): 408-415.
|
[6] |
Lian Haiwei, Yang Shuorui, Liu Renzhong.
Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway
[J]. Journal of International Oncology, 2022, 49(6): 321-326.
|
[7] |
Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.
MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2
[J]. Journal of International Oncology, 2022, 49(4): 193-198.
|
[8] |
Laibijiang Wusiman, Cao Bowei, Zhang Wenbin, Gao Hua.
Effects of exogenous AGR2 on the proliferation and invasion abilities of colon cancer cells
[J]. Journal of International Oncology, 2022, 49(2): 73-78.
|
[9] |
Jin Jiahui, Chen Cunhai, Ma Xuezhen.
Effects of radiation-associated miRNA in radiotherapy for breast cancer
[J]. Journal of International Oncology, 2022, 49(12): 735-738.
|
[10] |
Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.
Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer
[J]. Journal of International Oncology, 2022, 49(11): 681-686.
|
[11] |
Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.
Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis
[J]. Journal of International Oncology, 2022, 49(1): 45-50.
|
[12] |
Hong Anlan, Cao Meng, Wang Yan, Fang Fang.
Research progress on lncRNAs as members of ceRNA network in melanoma
[J]. Journal of International Oncology, 2022, 49(1): 61-64.
|
[13] |
Zhang Yongli, Zhang Ruojia, Fan Huancai, Ge Luna, Wang Lin.
TXNDC5-Prx2 axis regulates drug resistance of prostate cancer cells
[J]. Journal of International Oncology, 2021, 48(8): 473-478.
|
[14] |
Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.
Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis
[J]. Journal of International Oncology, 2021, 48(7): 409-414.
|
[15] |
Wang Yang, Liu Qian, Long Hui, Wu Qingming.
Research status of fecal detection for colorectal cancer markers
[J]. Journal of International Oncology, 2021, 48(7): 441-444.
|